# Reasoning trace — case_003 — repeat 1

- Case: `case_003` · ground truth: **CLL/SLL** (Chronic Lymphocytic Leukaemia (CLL))
- State: `completed`
- Model: `gpt-oss:20b` · think A/C: `medium` · think B: `medium` · seed: `production (-1)`
- Production prompt hash: `e86e3f7ad0d994fa561382808466a7c845c580e7a65d640313eb6261a258b22b` · report schema hash: `4f5934a345e1b9eea9947e3af96b79818010dafb772f94ed7a8e8bf43ea1f7e7`
- Rationale prompt hash: `31108bc22a5924af9a0da9b7ff3a2cc833e860fe3ecc163475d62b828a01115c` · rationale schema hash: `ff1eca1111057c0b7b84c7a3ac948114f74d1b6da959a8ad761555f3010a2ca8`
- Facts: 109 total — context=8, patient=61, who=40 · allowed citation ids: 111
- Arm A call: 97.65 s wall · prompt tokens 15135 · output tokens 2376 · done_reason `stop` · format `schema` · cached: False
- Arm B call: 125.247 s wall · prompt tokens 11983 · output tokens 3673 · done_reason `stop` · num_ctx 32768 · cached: False

## 1. Available information (what the model was given)

### immunophenotyping (16 facts)
| ids | field | value | evidence snippet |
| --- | --- | --- | --- |
| p_1 | CD5 | Positive | positive for CD5 |
| p_2 | CD19 | Positive | positive for CD5 CD19 |
| p_3 | CD20 | Positive | positive for CD5 CD19 CD20 |
| p_4 | CD23 | Positive | positive for CD5 CD19 CD20 CD23 |
| p_5 | CD81 | Weak | weak CD81 |
| p_6 | CD200 | Positive | positive for CD5 CD19 CD20 CD23 CD43 weak CD81 CD200 |
| p_7 | ROR1 | Negative | negative for ROR1 |
| p_8 | CD79b | Weak | weak CD79b |
| p_9 | CD43 | Positive | positive for CD5 CD19 CD20 CD23 CD43 |
| p_10 | CD10 | Negative | negative for ROR1 CD10 |
| p_11 | Kappa | Not performed |  |
| p_12 | Lambda | Weak | weak lambda expression |
| p_13 | CD11c | Not performed |  |
| p_14 | CD25 | Not performed |  |
| p_15 | CD103 | Not performed |  |
| p_16 | CD123 | Not performed |  |

### morphology (9 facts)
| ids | field | value | evidence snippet |
| --- | --- | --- | --- |
| p_17 | clefted_nucleus | Not mentioned | small mature lymphoid cells |
| p_18 | cll_sll_phenotype | Not mentioned | small mature lymphoid cells |
| p_19 | large_size | Negative | small mature lymphoid cells |
| p_20 | medium_size | Not mentioned | small mature lymphoid cells |
| p_21 | prolymphocyte | Not mentioned | small mature lymphoid cells |
| p_22 | prominent_nucleoli | Negative | inconspicuous nucleoli |
| p_23 | small_size | Positive | small mature lymphoid cells |
| p_24 | smear_cell | Positive | Frequent smudge cells are present. |
| p_25 | villous_projections | Not mentioned | small mature lymphoid cells |

### molecular (29 facts)
| ids | field | value | evidence snippet |
| --- | --- | --- | --- |
| p_26 | ATM_variant | Positive | Likely pathogenic missense variant in ATM c.9353dup p.(Variant206) at 10.1% VAF detected by NGS. |
| p_27 | ARID1A_variant | Negative | No pathogenic/likely pathogenic variants were detected in the regions analysed within the ARID1A, BCL2, BIRC3, BRAF, BTK, CARD11, CCND3, CD79B, CREBBP, CXCR4, EP300, EZH2, FOXO1, KLF2, MAP2K1, MEF2B, MYD88, NOTCH1, NOTCH2, PLCG2, NRAS, KRAS, HRAS, SF3B1, TP53 genes. |
| p_28 | BCL2_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_29 | BIRC3_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_30 | BRAF_V600E_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_31 | BRAF_nonV600E_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_32 | BTK_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_33 | CARD11_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_34 | CCND3_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_35 | CD79B_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_36 | CREBBP_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_37 | CXCR4_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_38 | EP300_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_39 | EZH2_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_40 | FOXO1_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_41 | KLF2_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_42 | MAP2K1_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_43 | MEF2B_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_44 | MYD88_L265P_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_45 | MYD88_nonL265P_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_46 | NOTCH1_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_47 | NOTCH2_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_48 | PLCG2_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_49 | NRAS_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_50 | KRAS_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_51 | HRAS_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_52 | SF3B1_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_53 | TP53_variant | Negative | No pathogenic/likely pathogenic variants were detected. |
| p_54 | IGHV_mutated | unmutated | this case belongs to the IG-unmutated category |

### cytogenetics (7 facts)
| ids | field | value | evidence snippet |
| --- | --- | --- | --- |
| p_55 | del_11q | Positive | clonal loss of ATM (at 11q22.3) |
| p_56 | del_13q | Not performed |  |
| p_57 | del_17p | Positive | clonal loss of TP53 (at 17p13.1) |
| p_58 | del_7q | Not performed |  |
| p_59 | gain_of_12 | Not performed |  |
| p_60 | t_11_14 | Negative | no evidence of a t(11;14)(q13;q32) translocation |
| p_61 | t_14_18 | Not performed |  |

### clinical context (8 facts)
| ids | field | value |
| --- | --- | --- |
| c_104 | hb | 132 |
| c_105 | plt | 232 |
| c_106 | neut | 4.9 |
| c_107 | wbc | 149.7 |
| c_108 | lymph | 143.2 |
| c_109 | paraprotein | Absent |
| c_110 | splenomegaly | Absent |
| c_111 | lymphadenopathy | Present |

### WHO 2022 grounding (40 facts across 8 diagnoses)
**CLL/SLL**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_62 | definition | Chronic lymphocytic leukaemia / small lymphocytic lymphoma (CLL/SLL) is a B-cell lymphoma comprising monomorphic small mature B cells that frequently coexpress CD5 and CD23. |
| w_63 | icd_o_coding | 9823/3 Chronic lymphocytic leukaemia / small lymphocytic lymphoma |
| w_64 | icd_11_coding | 2A82.0Z Chronic lymphocytic leukaemia or small lymphocytic lymphoma |
| w_65 | essential_diagnostic_criteria | See #32055. |
| w_66 | desirable_diagnostic_criteria | See #32055. |

**FL**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_67 | definition | Follicular lymphoma (FL) is a neoplasm of germinal-centre (GC) B cells with varying proportions of centrocytes and centroblasts. |
| w_68 | icd_o_coding | 9690/3 Follicular lymphoma |
| w_69 | icd_11_coding | 2A80.Z Follicular lymphoma, unspecified |
| w_70 | essential_diagnostic_criteria | Essential: B-cell lymphoma composed of varying proportions of centrocytes and/or centroblasts; immunophenotype compatible. |
| w_71 | desirable_diagnostic_criteria | Desirable: at least partly follicular growth pattern; BCL2 or BCL6 rearrangements. |

**HCL**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_72 | definition | Hairy cell leukaemia (HCL) is an indolent mature B-cell neoplasm composed of neoplastic cells with abundant cytoplasm and characteristic hairy projections. |
| w_73 | icd_o_coding | 9940/3 Hairy cell leukaemia |
| w_74 | icd_11_coding | 2A82.2 Hairy cell leukaemia |
| w_75 | essential_diagnostic_criteria | characteristic morphology in a blood or marrow smear; immunophenotype CD11c, CD25, CD103. |
| w_76 | desirable_diagnostic_criteria | clonal BRAF p.V600E mutation; positivity for CD123, CD200 (bright), cyclin D1. |

**LPL/WM**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_77 | definition | Lymphoplasmacytic lymphoma (LPL) is a neoplasm comprising small B lymphocytes, plasmacytoid lymphocytes, and plasma cells. |
| w_78 | icd_o_coding | 9671/3 Lymphoplasmacytic lymphoma |
| w_79 | icd_11_coding | 2A85.4 Lymphoplasmacytic lymphoma |
| w_80 | essential_diagnostic_criteria | Essential: significant bone marrow infiltration by clonal small lymphocytes with plasmacytoid and/or plasma cell differentiation; IgM+. |
| w_81 | desirable_diagnostic_criteria | Desirable: detection of MYD88 p.L265P; CXCR4 variant; monoclonal IgM. |

**MCL**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_82 | definition | Mantle cell lymphoma (MCL) is a mature B-cell neoplasm typically composed of small to medium-sized monomorphic cells expressing CD5, SOX11, and cyclin D1. |
| w_83, w_84, w_85 | icd_o_coding | 9673/3 Mantle cell lymphoma |
| w_86 | icd_11_coding | 2A85.5 Mantle cell lymphoma |
| w_87 | essential_diagnostic_criteria | Cyclin D1–positive MCL Essential: lymphoma cells of B lineage (positive for CD20 and usually CD5); cyclin D1 positivity. |
| w_88 | desirable_diagnostic_criteria | Cyclin D1–positive MCL Desirable: SOX11 expression positivity. |

**SBLPN**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_89 | definition | Splenic B-cell lymphoma/leukaemia with prominent nucleoli (SBLPN) is a splenic B-cell neoplasm with some but not all of the features of hairy cell leukaemia. |
| w_90 | icd_o_coding | 9591/3 Splenic B-cell lymphoma/leukaemia with prominent nucleoli |
| w_91 | icd_11_coding | 2A82.3 Splenic B-cell lymphoma or leukaemia, unclassifiable |
| w_92 | essential_diagnostic_criteria | Essential: circulating medium-sized lymphoid cells with prominent nucleoli or convoluted nuclei. |
| w_93 | desirable_diagnostic_criteria | Desirable: diffuse involvement of the splenic red pulp; absence of BRAF mutation. |

**SDRPL**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_94 | definition | Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is a small B-cell lymphoma involving the spleen, bone marrow, and peripheral blood. |
| w_95 | icd_o_coding | 9591/3 Splenic diffuse red pulp small B-cell lymphoma |
| w_96 | icd_11_coding | 2A82.Y Other specified mature B-cell neoplasm with leukaemic behaviour |
| w_97 | essential_diagnostic_criteria | diffuse infiltration of the spleen by monomorphic small B cells; peripheral blood with circulating small cells with villous projections. |
| w_98 | desirable_diagnostic_criteria | absence of BRAF p.V600E mutation; absence of lymphadenopathy. |

**SMZL**
| ids | field | value (truncated) |
| --- | --- | --- |
| w_99 | definition | Splenic marginal zone lymphoma (SMZL) is an indolent mature B-cell neoplasm primarily presenting in the spleen, often with villous lymphocytes in the peripheral blood. |
| w_100 | icd_o_coding | 9689/3 Splenic marginal zone lymphoma |
| w_101 | icd_11_coding | 2A82.Y Splenic marginal zone B-cell lymphoma |
| w_102 | essential_diagnostic_criteria | small B-cell lymphoma involving bone marrow and/or peripheral blood, composed of small lymphoid cells with villous processes; positive for IgM and IgD, negative for BCL6, ANXA1, CD103. |
| w_103 | desirable_diagnostic_criteria | neoplastic cells that are negative for CD5 and CD10. |

## 2. Model's own reasoning (arm A thinking, verbatim)

7058 characters. Diagnoses considered, in order of first mention: CLL/SLL (x31).

```
We need to produce integrated haematopathology report. Determine predicted_diagnosis.

Given evidence: immunophenotyping shows CD5+, CD19+, CD20+, CD23+, CD81 weak, CD200 positive, ROR1 negative, CD79b weak, CD43 positive, CD10 negative. Morphology: small_size positive, smear_cell positive, large_size negative, medium_size not mentioned, prolymphocyte not mentioned, prominent_nucleoli negative. So small mature B cells with CD5 and CD23 positivity typical of CLL/SLL. Also IGHV unmutated (p_54). del(11q) positive, del(17p) positive. t(11;14) negative. So fits CLL/SLL.

Also context: WBC 149.7, lymph 143.2 high, no paraprotein, splenomegaly absent but lymphadenopathy present. That could be SLL (nodal). But immunophenotype and cytogenetics support CLL/SLL. The presence of del(17p) indicates poor prognosis.

Thus predicted_diagnosis: CLL/SLL.

Now produce sections:

ICD codes: use WHO evidence w_63, w_64.

Summary of diagnosis: "IGHV unmutated; TP53 aberration present." citation ids: p_54 (IGHV) and p_57 (del17p). Also maybe p_53 for TP53 variant negative but del17p positive indicates TP53 aberration. Use p_57.

Additional comments: "del(11q) detected." citation id p_55.

Immunophenotyping: "CD5+, CD19+, CD20+, CD23+, CD200+, CD43+; CD10 negative; CD81 weak; CD79b weak; ROR1 negative." citation ids: p_1, p_2, p_3, p_4, p_6, p_9, p_10, p_5, p_8, p_7.

Morphology: "Small mature B cells; no prominent nucleoli." Use citations p_23, p_24, p_19, p_22.

Molecular: ATM variant positive (p_26). Also TP53 variant negative (p_53) but del17p present.

Cytogenetics: del(11q) positive, del(17p) positive, t(11;14) negative (p_60).

Now produce JSON.
```

## 3. Delivered report (arm A raw output replayed through the engine parser)

predicted_diagnosis raw: **CLL/SLL** · delivered: **CLL/SLL** · contract_valid: False · failure_kind: `citation_contract_warning`

Removed by post-processing (uncited informative segments the model wrote but the engine deleted):
- Summary of diagnosis: Diagnosis: CLL/SLL

Raw model JSON:
```json
{
  "predicted_diagnosis": "CLL/SLL",
  "sections": [
    {"title": "ICD codes:", "segments": [
      {"text": "ICD-O-3: 9823/3 Chronic lymphocytic leukaemia / small lymphocytic lymphoma", "citation_ids": ["w_63"]},
      {"text": "ICD-11: 2A82.0Z Chronic lymphocytic leukaemia or small lymphocytic lymphoma", "citation_ids": ["w_64"]}]},
    {"title": "Summary of diagnosis:", "segments": [
      {"text": "Diagnosis: CLL/SLL", "citation_ids": []},
      {"text": "Summary: IGHV unmutated; TP53 aberration present.", "citation_ids": ["p_54","p_57"]},
      {"text": "Additional comments: del(11q) detected.", "citation_ids": ["p_55"]}]},
    {"title": "Immunophenotyping:", "segments": [
      {"text": "CD5+, CD19+, CD20+, CD23+, CD200+, CD43+; CD10 negative; CD81 weak; CD79b weak; ROR1 negative.", "citation_ids": ["p_1","p_2","p_3","p_4","p_6","p_9","p_10","p_5","p_8","p_7"]}]},
    {"title": "Morphology:", "segments": [
      {"text": "Small mature B cells; no prominent nucleoli.", "citation_ids": ["p_23","p_24","p_22"]}]},
    {"title": "Molecular:", "segments": [
      {"text": "ATM variant detected.", "citation_ids": ["p_26"]}]},
    {"title": "Cytogenetics:", "segments": [
      {"text": "del(11q) and del(17p) present.", "citation_ids": ["p_55","p_57"]}]}
  ]
}
```

## 4. Structured rationale (arm B)

Decision: **CLL/SLL** · confidence: high · agrees with delivered report: True

### Key findings
| modality | finding | ids |
| --- | --- | --- |
| immunophenotyping | CD5 positivity | p_1 |
| immunophenotyping | CD23 positivity | p_4 |
| morphology | Small mature B‑cell morphology (small size, smear cell positive) | p_23, p_24 |
| molecular | ATM gene variant present | p_26 |
| cytogenetics | del(11q) cytogenetic abnormality | p_55 |
| cytogenetics | del(17p) cytogenetic abnormality | p_57 |
| clinical_context | Marked lymphocytosis (lymph count 143.2 ×10⁹/L, WBC 149.7 ×10⁹/L) | c_107, c_108 |
| clinical_context | Lymphadenopathy present | c_111 |

### Differential
| diagnosis | verdict | supporting | contradicting | WHO criteria | rationale |
| --- | --- | --- | --- | --- | --- |
| CLL/SLL | favoured | p_1, p_4, p_23, p_24, p_26, p_55, p_57, c_107, c_108, c_111 |  | met 3 / not met 0 / n.a. 0 | The patient shows the classic immunophenotype (CD5+, CD23+) and small mature B‑cell morphology, with cytogenetic abnormalities (del11q, del17p) and high lymphocytosis typical of CLL/SLL. |
| FL | unlikely |  | p_10, p_23 | met 0 / not met 1 / n.a. 1 | Absence of germinal‑center markers (CD10 negative) and lack of follicular morphology make FL unlikely. |
| HCL | unlikely |  | p_30, p_25 | met 0 / not met 1 / n.a. 1 | BRAF mutation is absent and villous projections were not described, arguing against HCL. |
| LPL/WM | unlikely |  | c_109, p_23 | met 0 / not met 1 / n.a. 1 | No IgM paraprotein and no plasmacytoid morphology exclude LPL/WM. |
| MCL | unlikely |  | p_4 | met 0 / not met 0 / n.a. 2 | CD23 positivity and lack of cyclin D1 data make MCL unlikely. |
| SBLPN | unlikely |  | p_23 | met 0 / not met 1 / n.a. 0 | The cells are small and lack prominent nucleoli, inconsistent with SBLPN. |
| SDRPL | unlikely |  | c_110, p_25 | met 1 / not met 0 / n.a. 1 | Absence of splenomegaly and lack of villous projections argue against SDRPL. |
| SMZL | unlikely |  | p_1, c_109 | met 0 / not met 2 / n.a. 0 | The patient is CD5 positive and IgM negative, which excludes SMZL. |

### WHO criteria, per diagnosis
**CLL/SLL** (favoured)
| criterion | status | ids |
| --- | --- | --- |
| CD5 positivity | met | w_62, p_1 |
| CD23 positivity | met | w_62, p_4 |
| Small mature B‑cell morphology | met | w_62, p_23 |

**FL** (unlikely)
| criterion | status | ids |
| --- | --- | --- |
| CD10 positivity (GC marker) | not_met | w_70, p_10 |
| BCL6 or MEF2B expression | not_assessable | w_70 |

**HCL** (unlikely)
| criterion | status | ids |
| --- | --- | --- |
| BRAF V600E mutation | not_met | w_75, p_30 |
| Villous cytoplasmic projections | not_assessable | w_75, p_25 |

**LPL/WM** (unlikely)
| criterion | status | ids |
| --- | --- | --- |
| IgM monoclonal component | not_met | w_80, c_109 |
| Plasmacytoid differentiation | not_assessable | w_80 |

**MCL** (unlikely)
| criterion | status | ids |
| --- | --- | --- |
| Cyclin D1 positivity | not_assessable | w_87 |
| SOX11 expression | not_assessable | w_87 |

**SBLPN** (unlikely)
| criterion | status | ids |
| --- | --- | --- |
| Medium‑sized cells with prominent nucleoli | not_met | w_92, p_23 |

**SDRPL** (unlikely)
| criterion | status | ids |
| --- | --- | --- |
| Villous cytoplasmic projections | not_assessable | w_97, p_25 |
| BRAF V600E mutation absent | met | w_97, p_30 |

**SMZL** (unlikely)
| criterion | status | ids |
| --- | --- | --- |
| IgM positivity | not_met | w_102, c_109 |
| CD5 negativity | not_met | w_102, p_1 |

### Decision detail
- Discriminator: CD5+ and CD23+ immunophenotype with small mature B‑cell morphology `[p_1, p_4, p_23]`
- Discriminator: Presence of del(11q) and del(17p) cytogenetic abnormalities `[p_55, p_57]`
- Unresolved: Absolute B‑cell count not provided to confirm CLL versus SLL
- Unresolved: Lymph node histology not available
- Would change the diagnosis: If CD23 were negative or if the cells expressed CD10 and BCL6, FL would become more likely.
- Would change the diagnosis: Detection of a BRAF V600E mutation or villous projections would support HCL.
- Would change the diagnosis: Identification of IgM monoclonal protein or plasmacytoid differentiation would favor LPL/WM.

## 5. Discriminator ablation (arm C)

Removed 5 fact(s) named as key discriminators; delivered diagnosis without them: **CLL/SLL** (was CLL/SLL) · changed: False
| ids | source | field | value |
| --- | --- | --- | --- |
| p_1 | patient | CD5 | Positive |
| p_4 | patient | CD23 | Positive |
| p_23 | patient | small_size | Positive |
| p_55 | patient | del_11q | Positive |
| p_57 | patient | del_17p | Positive |

## 6. Audit checks

- PASS Delivered diagnosis matches ground truth — CLL/SLL vs CLL/SLL
- FAIL Report contract valid (no engine warnings) — citation_contract_warning
- FAIL Thinking considered more than one diagnosis
- FAIL Stated discriminators are load-bearing (diagnosis changes without them) — CLL/SLL -> CLL/SLL
- FAIL Every patient/context fact was referenced in thinking or rationale — 38 ignored
